AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · IEX Real-Time Price · USD
2.250
-0.310 (-12.11%)
At close: Jul 19, 2024, 4:00 PM
2.341
+0.091 (4.04%)
Pre-market: Jul 22, 2024, 9:14 AM EDT
AEON Biopharma Employees
AEON Biopharma had 10 employees as of December 31, 2023. The number of employees increased by 2 or 25.00% compared to the previous year.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$32,395,400
Market Cap
88.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Dec 31, 2022 | 8 | -12 | -60.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 773 |
| Alpha Teknova | 211 |
| HilleVax | 90 |
| InflaRx | 62 |
| BeyondSpring | 36 |
| Eton Pharmaceuticals | 30 |
| Clearside Biomedical | 30 |
| Eupraxia Pharmaceuticals | 29 |
AEON News
- 7 weeks ago - AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan - GlobeNewsWire
- 2 months ago - AEON Biopharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - AEON Biopharma Provides Update on Development Pipeline - GlobeNewsWire
- 2 months ago - AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - GlobeNewsWire
- 4 months ago - CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants - GlobeNewsWire
- 4 months ago - AEON Biopharma Announces Redemption of Public Warrants - GlobeNewsWire
- 4 months ago - AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine - GlobeNewsWire